Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.

about

Neoadjuvant versus definitive chemoradiotherapy for locally advanced esophageal cancer : Outcomes and patterns of failure.

Item

http://www.wikidata.org/entity/Q48336173

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Neoadjuvant versus definitive ...... comes and patterns of failure.

@en

Neoadjuvant versus definitive ...... comes and patterns of failure.

@nl

type

Item

label

Neoadjuvant versus definitive ...... comes and patterns of failure.

@en

Neoadjuvant versus definitive ...... comes and patterns of failure.

@nl

prefLabel

Neoadjuvant versus definitive ...... comes and patterns of failure.

@en

Neoadjuvant versus definitive ...... comes and patterns of failure.

@nl

P1476

Neoadjuvant versus definitive ...... comes and patterns of failure.

@en

P2093

Florian Sterzing

http://www.w3.org/2001/XMLSchema#string

Kristin Lang

http://www.w3.org/2001/XMLSchema#string

Lorenz Uhlmann

http://www.w3.org/2001/XMLSchema#string

Matthias Felix Haefner

http://www.w3.org/2001/XMLSchema#string

Stefan Alexander Koerber

http://www.w3.org/2001/XMLSchema#string

Vivek Verma

http://www.w3.org/2001/XMLSchema#string

P2860

Distribution and timing of distant metastasis after local therapy in a large cohort of patients with esophageal and esophagogastric junction cancer

A nomogram that predicts pathologic complete response to neoadjuvant chemoradiation also predicts survival outcomes after definitive chemoradiation for esophageal cancer.

Comparison of dosimetric parameters and toxicity in esophageal cancer patients undergoing 3D conformal radiotherapy or VMAT.

Radiation Therapy and Cardiac Death in Long-Term Survivors of Esophageal Cancer: An Analysis of the Surveillance, Epidemiology, and End Result Database

Patient-reported outcomes during and after definitive chemoradiotherapy for oesophageal cancer.

Resection for esophageal cancer: strategies for optimal management.

Predictors of postoperative complications after trimodality therapy for esophageal cancer.

Systematic review of the benefits and risks of neoadjuvant chemoradiation for oesophageal cancer.

Meta-analysis of neoadjuvant treatment modalities and definitive non-surgical therapy for oesophageal squamous cell cancer.

Is cardiac toxicity a relevant issue in the radiation treatment of esophageal cancer?

P2888

s00066-017-1211-0

P304

116-124

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00066-017-1211-0

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

194

http://www.w3.org/2001/XMLSchema#string

P50

Jürgen Debus

P577

2017-09-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

28916906

http://www.w3.org/2001/XMLSchema#string

P921

chemoradiotherapy